Literature DB >> 10936206

In Alzheimer's disease, heme oxygenase is coincident with Alz50, an epitope of tau induced by 4-hydroxy-2-nonenal modification.

A Takeda1, M A Smith, J Avilá, A Nunomura, S L Siedlak, X Zhu, G Perry, L M Sayre.   

Abstract

In this study, we compared the neuronal induction of the antioxidant heme oxygenase-1 (HO-1) in Alzheimer's disease with abnormalities in tau marked by antibodies recognizing either phosphorylation (AT8) or conformational change (Alz50). The epitope recognized by Alz50 shows a complete overlap with HO-1-containing neurons, but AT8 recognized these neurons as well as neurons not displaying HO-1. These findings suggest that tau phosphorylation precedes the HO-1 response and that HO-1 is coincident with the Alz50 epitope. This led us to consider whether oxidative damage plays a role in forming the Alz50 epitope. We found that 4-hydroxy-2-nonenal (HNE), a highly reactive product of lipid peroxidation, reacts with normal tau and induces the Alz50 epitope in tau. It is important that the ability of HNE to create the Alz50 epitope not only is dependent on lysine residues of tau but also requires tau phosphorylation because neither methylated, recombinant, nor dephosphorylated tau reacts with HNE to create the Alz50 epitope. Supporting the in vivo relevance of this observation, endogenous paired helical filament-tau isolated from subjects with Alzheimer's disease was immunoreactive with an antibody to a stable HNE-lysine adduct, as were all vulnerable neurons in subjects with Alzheimer's disease but not in control individuals. Together, these findings support the involvement of oxidative damage early in neurofibrillary tangle formation in Alzheimer's disease and also suggest that HNE modification contributes to the generation of the tau conformation defining the Alz50 epitope. These findings provide evidence that an interplay between phosphorylation of tau and neuronal oxidative stress-induced pathology is important in the formation of neurofibrillary tangles.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10936206     DOI: 10.1046/j.1471-4159.2000.0751234.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  46 in total

Review 1.  Oxidative imbalance in Alzheimer's disease.

Authors:  Xiongwei Zhu; Hyoung-Gon Lee; Gemma Casadesus; Jesus Avila; Kelly Drew; George Perry; Mark A Smith
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

Review 2.  A novel perspective on tau in Alzheimer's disease.

Authors:  D J Bonda; R J Castellani; X Zhu; A Nunomura; H-g Lee; G Perry; M A Smith
Journal:  Curr Alzheimer Res       Date:  2011-09       Impact factor: 3.498

3.  Polymerization of hyperphosphorylated tau into filaments eliminates its inhibitory activity.

Authors:  Alejandra del C Alonso; Bin Li; Inge Grundke-Iqbal; Khalid Iqbal
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-30       Impact factor: 11.205

4.  Phosphorylation inhibits turnover of the tau protein by the proteasome: influence of RCAN1 and oxidative stress.

Authors:  Diana Poppek; Susi Keck; Gennady Ermak; Tobias Jung; Alexandra Stolzing; Oliver Ullrich; Kelvin J A Davies; Tilman Grune
Journal:  Biochem J       Date:  2006-12-15       Impact factor: 3.857

5.  Treatment with a γ-ketoaldehyde scavenger prevents working memory deficits in hApoE4 mice.

Authors:  Sean S Davies; Chris Bodine; Elena Matafonova; Brooke G Pantazides; Nathalie Bernoud-Hubac; Fiona E Harrison; Sandra J Olson; Thomas J Montine; Venkataraman Amarnath; L Jackson Roberts
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

Review 6.  Antioxidant therapy in Alzheimer's disease: theory and practice.

Authors:  Gjumrakch Aliev; Mark E Obrenovich; V Prakash Reddy; Justin C Shenk; Paula I Moreira; Akihiko Nunomura; Xiongwei Zhu; Mark A Smith; George Perry
Journal:  Mini Rev Med Chem       Date:  2008-11       Impact factor: 3.862

7.  The essential role of ERK in 4-oxo-2-nonenal-mediated cytotoxicity in SH-SY5Y human neuroblastoma cells.

Authors:  Hyun-Pil Lee; Xiaochun Zhu; Xiongwei Zhu; S Chad Skidmore; George Perry; Lawrence M Sayre; Mark A Smith; Hyoung-Gon Lee
Journal:  J Neurochem       Date:  2009-01-13       Impact factor: 5.372

Review 8.  Chronic traumatic encephalopathy-integration of canonical traumatic brain injury secondary injury mechanisms with tau pathology.

Authors:  Jacqueline R Kulbe; Edward D Hall
Journal:  Prog Neurobiol       Date:  2017-08-26       Impact factor: 11.685

Review 9.  Oxidative stress in diabetes and Alzheimer's disease.

Authors:  V Prakash Reddy; Xiongwei Zhu; George Perry; Mark A Smith
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

10.  Nitration of tau protein is linked to neurodegeneration in tauopathies.

Authors:  Takashi Horiguchi; Kunihiro Uryu; Benoit I Giasson; Harry Ischiropoulos; Richard LightFoot; Christine Bellmann; Christiane Richter-Landsberg; Virginia M-Y Lee; John Q Trojanowski
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.